Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human FLT4 Anticorps:
anti-Mouse (Murine) FLT4 Anticorps:
anti-Rat (Rattus) FLT4 Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Mouse (Murine) Polyclonal FLT4 Primary Antibody pour CyTOF, FACS - ABIN4899930
Benedito, Rocha, Woeste, Zamykal, Radtke, Casanovas, Duarte, Pytowski, Adams: Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. dans Nature 2012
Show all 51 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896919
Shawber, Funahashi, Francisco, Vorontchikhina, Kitamura, Stowell, Borisenko, Feirt, Podgrabinska, Shiraishi, Chawengsaksophak, Rossant, Accili, Skobe, Kitajewski: Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. dans The Journal of clinical investigation 2007
Show all 7 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour FACS - ABIN4896918
Roorda, Ter Elst, Scherpen, Meeuwsen-de Boer, Kamps, de Bont: VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27(KIP1) via paracrine mechanisms. dans European journal of cancer (Oxford, England : 1990) 2010
Show all 7 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour WB - ABIN1882290
Pajusola, Aprelikova, Korhonen, Kaipainen, Pertovaara, Alitalo, Alitalo: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. dans Cancer research 1992
Show all 5 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour ELISA (Detection), FACS - ABIN4899932
Mouawad, Spano, Comperat, Capron, Khayat: Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome. dans European journal of cancer (Oxford, England : 1990) 2009
Show all 4 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour ELISA, WB - ABIN969147
Goodyear, Kheyfets, Garcia, Stearns: Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines. dans The Prostate 2009
Show all 3 Pubmed References
Human Polyclonal FLT4 Primary Antibody pour FACS, IF (p) - ABIN678578
Wang, Zhou, Lin, Wang, Lin, Li: RhGH attenuates ischemia injury of intrahepatic bile ducts relating to liver transplantation. dans The Journal of surgical research 2011
Show all 3 Pubmed References
Mouse (Murine) Monoclonal FLT4 Primary Antibody pour IHC (fro), IHC (p) - ABIN967368
Kubo, Fujiwara, Jussila, Hashi, Ogawa, Shimizu, Awane, Sakai, Takabayashi, Alitalo, Yamaoka, Nishikawa: Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. dans Blood 2000
Show all 2 Pubmed References
Mouse (Murine) Polyclonal FLT4 Primary Antibody pour ELISA (Detection), FACS - ABIN4899929
Gale, Prevo, Espinosa, Ferguson, Dominguez, Yancopoulos, Thurston, Jackson: Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. dans Molecular and cellular biology 2007
Show all 2 Pubmed References
Human Monoclonal FLT4 Primary Antibody pour IHC, ELISA - ABIN1589703
Rohringer, Holnthoner, Hackl, Weihs, Rünzler, Skalicky, Karbiener, Scheideler, Pröll, Gabriel, Schweighofer, Gröger, Spittler, Grillari, Redl: Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells. dans PLoS ONE 2014
VEGFR-3 and CAV3 (Montrer CAV3 Anticorps) expression demonstrated immunohistochemically in SMCs of the tunica media of SV grafts predicted their early restenosis in triple-vessel CAD (Montrer CAD Anticorps) patients. CAV2 (Montrer CAV2 Anticorps) protein expression in SMCs of ITA (Montrer BIRC2 Anticorps) grafts indicated the risk of early graft failure both in double-vessel and triple-vessel CAD (Montrer CAD Anticorps) subjects.
Single nucleotide polymorphism of VEGFR3 is associated with relapse in gastroenteropancreatic neuroendocrine neoplasms.
VEGFR3 single nucleotide polymorphisms association with lymphedema caused by Wuchereria bancrofti.
The results imply a very good sensitivity of VEGFR-3 in ESCC. VEGFR-3 may be a good diagnostic biomarker for ESCC.
VEGFR-3 expression was associated with depth of invasion and lymph node metastasis in gastric cancer
The finding of rare LAMA5 (Montrer LAMA5 Anticorps) variants together with FLT4 in Milroy disease suggests that these mutations may be co-responsible for these disorders and most likely interfere with the function of lymphatics.
the difference between the pro- (VEGF165a) and antiangiogenic (VEGF165b) VEGF (Montrer VEGFA Anticorps) isoforms and its soluble receptors for severity of diabetic retinopathy, is reported.
Rare inherited and de novo variants in 2,871 congenital heart disease probands identified GDF1 (Montrer GDF1 Anticorps), MYH6 (Montrer MYH6 Anticorps), and FLT4 as causative genes.
Data show that VEGF-C (Montrer VEGFC Anticorps), VEGF-D (Montrer Figf Anticorps), and VEGFR-3 were expressed in a substantial percentage of breast carcinomas.
There was a significant decrease in VEGFR3 expression in pulmonary arterial endothelial cells from pulmonary arterial hypertension patients.
Fluid shear stress regulates vascular remodeling via VEGFR-3 activation, independently of its ligand, VEGF-C (Montrer VEGFC Anticorps), in the uterus during pregnancy.
Genetic depletion experiments revealed that VEGFR2 (Montrer KDR Anticorps), but not VEGFR3, is indispensable for maintenance of thyroid vascular integrity. Notably, blockade of VEGF-A (Montrer VEGFA Anticorps) or VEGFR2 (Montrer KDR Anticorps) not only abrogated vascular remodeling but also inhibited follicular hypertrophy, which led to the reduction of thyroid weights during goitrogenesis.
Report the generation of a Vegfr3-CreER (T2) knockin mouse by gene targeting in embryonic stem cells. This mouse expresses the tamoxifen-inducible CreER(T2) recombinase (Montrer RAG1 Anticorps) under the endogenous transcriptional control of the Vegfr3 gene without altering its physiological expression or regulation in the lymphatic system.
Lymphangiogenic growth in the diaphragm was highly dependent on vascular endothelial growth factor (Montrer VEGF Anticorps) receptor (Montrer RYK Anticorps) (VEGFR)-3 signaling. During diaphragm development, macrophages appeared first in a linearly arranged pattern, followed by ingrowth of lymphatic vessels along these patterned lines.
CLEC14A (Montrer CLEC14A Anticorps) acts in vascular homeostasis by fine-tuning VEGFR-2 (Montrer KDR Anticorps) and VEGFR-3 signaling in endothelial cells
VEGFR3 limits VEGFR2 (Montrer KDR Anticorps) expression and VEGF (Montrer VEGFA Anticorps)/VEGFR2 (Montrer KDR Anticorps) pathway activity in quiescent and angiogenic blood vascular endothelial cells, thereby preventing excessive vascular permeability.
Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Vegf-d (Montrer Figf Anticorps) and its receptor Vegfr-3 were more highly expressed in lungs of hyperoxic, versus normoxic, wild-type mice, indicating that components of the Vegf-d (Montrer Figf Anticorps) signalling pathway are up-regulated in hyperoxia.
this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8 (Montrer LGALS8 Anticorps)-dependent crosstalk among VEGF-C (Montrer VEGFC Anticorps), podoplanin (Montrer PDPN Anticorps) and integrin pathways plays a key role.
Tnfsf15 (Montrer TNFSF15 Anticorps), a cytokine produced largely by endothelial cells, facilitates lymphangiogenesis by up-regulating Vegfr3 gene expression in LECs, contributing to the maintenance of the homeostasis of the circulatory system.
miR (Montrer MYLIP Anticorps)-126a directs lymphatic endothelial cell sprouting and extension by interacting with Cxcl12a-mediated chemokine (Montrer CCL1 Anticorps) signaling and Vegfc (Montrer VEGFC Anticorps)-Flt4 signal axis.
Ca(2 (Montrer CA2 Anticorps)+) oscillations depended upon VEGF receptor-2 (Vegfr2) and Vegfr3 in endothelial cells budding from the dorsal aorta (DA) and posterior cardinal (Montrer CARD8 Anticorps) vein, respectively.
Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling
In the embryo, phenotypes driven by increased Vegfc (Montrer VEGFC Anticorps) are suppressed in the absence of Ccbe1 (Montrer CCBE1 Anticorps), and Vegfc (Montrer VEGFC Anticorps)-driven sprouting is enhanced by local Ccbe1 (Montrer CCBE1 Anticorps) overexpression. Moreover, Vegfc (Montrer VEGFC Anticorps)- and Vegfr3-dependent Erk (Montrer MAPK1 Anticorps) signaling is impaired in the absence of Ccbe1 (Montrer CCBE1 Anticorps).
Flt4 plays an essential role in lymphangiogenesis [review]
The parallel growth of motoneuron axons with the dorsal aorta depends on Vegfc (Montrer VEGFC Anticorps)/Vegfr3 signaling in zebrafish.
Rspo1-Wnt-VegfC-Vegfr3 signaling plays a crucial role as an endothelial-autonomous permissive cue for developmental angiogenesis.
flt4 signalling is suppressed by Dll4 (Montrer DLL4 Anticorps) in developing zebrafish intersegmental arteries.
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA.
, fms-like tyrosine kinase 4
, soluble VEGFR3 variant 1
, soluble VEGFR3 variant 2
, soluble VEGFR3 variant 3
, tyrosine-protein kinase receptor FLT4
, vascular endothelial growth factor receptor 3
, chylous ascites
, receptor protein tyrosine kinase
, vascular endothelial growth factor receptor-3
, FMS-like tyrosine kinase 4
, tyrosine kinase VEGFR-3
, receptor tyrosine kinase Flt4